98%
921
2 minutes
20
Unlabelled: We aimed to validate the performance of ddPCR-GNB, a plasma droplet digital PCR panel targeting the four most common gram-negative bacteria, for patients with suspected bloodstream infection (BSI). Patients suspected of having BSIs were prospectively enrolled. The results of blood culture and ddPCR-GNB were compared, and cases with discordant results were arbitrated on the basis of additional microbiological results and clinical evidence. A total of 1,041 patients were enrolled. Blood culture and ddPCR-GNB results were positive for targeted bacteria in 6.3% and 31.7% of patients, respectively. The overall per-patient sensitivity and specificity of ddPCR-GNB for proven BSIs were 98.5% (95% CI, 91.9% to 99.9%) and 72.8% (95% CI, 69.9% to 75.5%), respectively; the negative predictive value was 99.9% (95% CI, 99.2% to 100%). The discordant results included 265 cases (25.5%) with negative companion blood culture results but positive ddPCR-GNB results and one case vice versa. A total of 23.7% of the cases were attributed to probable ( = 126) or possible ( = 121) BSIs. If both probable and possible BSIs were assumed to be true positives, the per-patient specificity of ddPCR-GNB would be 97.5%. The ddPCR-GNB panel demonstrated excellent microbial diagnostic performance in identifying targeted bacteria for patients with suspected BSI.
Importance: This is the first multicentral study to validate the clinical performance of ddPCR in etiological diagnosis of bloodstream infection. The results showed that ddPCR has high sensitivity and increased detection rate compared with blood culture. The study proved the potential of the ddPCR method in microbial diagnoses.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11960046 | PMC |
http://dx.doi.org/10.1128/spectrum.01015-24 | DOI Listing |
Clin Infect Dis
September 2025
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background: A shortage of BD BACTECTM blood culture bottles occurred in 2024. We describe the clinical impact of that shortage.
Methods: We conducted a National Healthcare Safety Network (NHSN) questionnaire and retrospective cohort study using inpatient hospitalization data from the Premier Healthcare Database.
Antimicrob Steward Healthc Epidemiol
September 2025
Emergency and Trauma Centre, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Objective: To determine the frequency and outcomes of early follow-up blood cultures (BCs) collected within 48 hours of patients being investigated for bacteremia in the emergency department (ED), as well as the number of new pathogens isolated.
Design: Retrospective observational study of patients who had BCs collected in the ED between October 2019 and July 2020.
Methods: This study was conducted in a large, metropolitan ED with annual census of over 82,000 adult presentations.
Appl Biosaf
August 2025
Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Background: Serum and other blood-derived products are widely used in biomedical and biopharmaceutical processes, especially for the production of vaccines or cell therapeutic applications. To ensure quality and safety, each serum lot undergoes testing for sterility to minimize the risk of disease transmission. A currently performed standard procedure is gamma-irradiation of serum for effectively killing pathogens.
View Article and Find Full Text PDFRev Cardiovasc Med
August 2025
The Second Clinical College of Fujian Medical University, 362000 Quanzhou, Fujian, China.
Blood culture-negative infective endocarditis (BCNE) constitutes an important subtype of infective endocarditis. Despite the rarity of BCNE, this subtype poses a significant diagnostic challenge and promotes a high mortality rate. Recent advances in diagnostic modalities have facilitated the rapid identification of BCNE.
View Article and Find Full Text PDFVet Dermatol
September 2025
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, USA.
Background: The antibacterial efficacy of chlorhexidine shampoo is directly affected by formulation and bathing factors.
Hypothesis/objective: To evaluate the in vitro antibacterial efficacy of chlorhexidine-containing shampoos at various dilutions and to compare their lathering ability.
Animals: No animals were utilised in this study.